Corneal Crosslinking: Present and Future
- PMID: 36094381
- DOI: 10.1097/APO.0000000000000557
Corneal Crosslinking: Present and Future
Abstract
Keratoconus is a progressive corneal thinning disorder that can lead to vision loss. In the last 2 decades, corneal crosslinking (CXL) has emerged as an effective method to halt the progression of keratoconus and reduce the number of patients requiring keratoplasty. The procedure has been adopted globally and has evolved to become a part of combination treatments to regularize the cornea and improve visual outcomes. CXL has even been extrapolated in managing other ocular pathologies such as progressive myopia, infectious keratitis, and bullous keratopathy. This review aims to summarize the current role of CXL in keratoconus and its alternative uses, and provide insights into future developments in this fast-developing field.
Copyright © 2022 Asia-Pacific Academy of Ophthalmology. Published by Wolters Kluwer Health, Inc. on behalf of the Asia-Pacific Academy of Ophthalmology.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Ziaei M, Barsam A, Shamie N, et al. Reshaping procedures for the surgical management of corneal ectasia. J Cataract Refract Surg. 2015;41:842–872.
-
- Goh YW, Gokul A, Yadegarfar ME, et al. Prospective clinical study of keratoconus progression in patients awaiting corneal cross-linking. Cornea. 2020;39:1256–1260.
-
- Crawford AZ, Zhang J, Gokul A, et al. The enigma of environmental factors in keratoconus. Asia Pac J Ophthalmol (Phila). 2020;9:549–556.
-
- Althomali TA, Al-Qurashi IM, Al-Thagafi SM, et al. Prevalence of keratoconus among patients seeking laser vision correction in Taif area of Saudi Arabia. Saudi J Ophthalmol. 2018;32:114–118.
-
- McGhee CNJ, Kim BZ, Wilson PJ. Contemporary treatment paradigms in keratoconus. Cornea. 2015;34:16–23.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources